cgp 20712a has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrionuevo, M; Cenarruzabeitia, E; MartÃnez, JA; Milagro, FI | 1 |
| Chess-Williams, R; Sellers, DJ | 1 |
2 other study(ies) available for cgp 20712a and Alloxan Diabetes
| Article | Year |
|---|---|
Potential anti-diabetic applications of a new molecule with affinity for beta 3-adrenoceptors.
Topics: Adipose Tissue; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Benzyl Alcohols; Blood Glucose; Diabetes Mellitus, Experimental; Esophagus; Female; Guinea Pigs; Imidazoles; Insulin; Muscle Relaxation; Muscle, Smooth; Oxygen Consumption; Propanolamines; Rats; Rats, Wistar; Triglycerides | 1996 |
The effect of streptozotocin-induced diabetes on cardiac beta-adrenoceptor subtypes in the rat.
Topics: Adrenergic beta-Agonists; Animals; Binding Sites; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Dihydroalprenolol; Heart Rate; Imidazoles; Isoproterenol; Male; Myocardium; Perfusion; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Stimulation, Chemical; Streptozocin | 2001 |